FIRST TRUST NYSE ARCA BIOTECHNOLOGY INDE: (AMEX: FBT)
Jun 17 03:59 PM ET
BENCHMARK for FBT
NYSE ARCA BIOTECHNOLOGY INDEX
This Index is an equal dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. Eg, recombinant DNA technology, molecular biology, genetic engineering, monoclonal antibody-based technology, lipid/liposome technology, and genomics.
FUND SUMMARY FOR FBT
FIRST TRUST NYSE ARCA BIOTECHNOLOGY INDE
This Fund is an exchange-traded index fund or Index ETF which is a separate investment portfolio of the First Trust Exchange-Traded Fund, an open-end management investment company. The First Trust NYSE Arca Biotechnology Index Fund seeks investment results that correspond generally to the price and yield, before fees and expenses, of the NYSE Arca Biotechnology Index.
Zacks Commentary For FBT
Zacks Blog: Zacks Investment Ideas feature highlights: Market Vectors Biotech ETF, iShares Nasdaq Biotechnology ETF, Regeneron, Celgene and First Trust Amex Biotechnology...
Jun 12, 2013
Zacks Blog: 3 Impressive Biotech ETFs Crushing the Market
Jun 11, 2013
Zacks Blog: Biotechnology ETF Investing 101
May 20, 2013
Zacks Blog: Is the Biotech Sector Still a Market Leader?
Apr 25, 2013
Zacks ETF Rank : FBT
Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.
News For FBT
Jun 13, 2013
Jun 3, 2013
First Trust AMEX Biotechnology Index Fund Has Returned 32.8% Since SmarTrend Recommendation (FBT) - Comtex Smartrend(R)
May 29, 2013
NYSE Arca Biotech Index (FBT) Showing Bullish Technicals With Resistance At $61.85 - Freshbrewedmedia
May 23, 2013